Pasithea therapeutics corp ktta
WebPasithea Therapeutics is a biotechnology company primarily focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) … Web23 Nov 2024 · Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules Globe Newswire - Wed Nov 24, 2024 . MIAMI BEACH, Fla., Nov. 24, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a …
Pasithea therapeutics corp ktta
Did you know?
WebPrestigious award presented by Society for Brain Mapping & Therapeutics (SBMT) and the World Brain Mapping FoundationPALO ALTO, Calif. and MIAMI, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) --... Web27 Mar 2024 · Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to …
Web22 Mar 2024 · Pasithea Therapeutics Corp ’s (KTTA) stock price is $0.433 and Pasithea Therapeutics Corp ’s (KTTA) 100-day simple moving average is 0.75, creating a Sell signal. Pasithea Therapeutics Corp ’s ( KTTA ) stock price is $0.433 and Pasithea Therapeutics Corp ’s ( KTTA ) 200-day simple moving average is 0.95 , creating a Sell signal.
Web31 Mar 2024 · Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological... WebThe Pasithea Therapeutics Corp. stock prediction for 2025 is currently $ 0.143366, assuming that Pasithea Therapeutics Corp. shares will continue growing at the average …
Web31 Mar 2024 · Pasithea Therapeutics Corp. is a biotechnology company. The Company is engaged on psychiatric and neurological research regarding central nervous system (CNS) disorders with focus on translating the research into clinic-ready drugs. The Company's secondary operations are focused on establishing anti-depression clinics across the …
WebPasithea Therapeutics Corp. (KTTA) Latest Press Releases & Corporate News - Yahoo Finance U.S. markets closed (-1.76%) Pasithea Therapeutics Corp. (KTTA) NasdaqCM - NasdaqCM Delayed Price.... roberts exxon weslayanWebCompany profile for Pasithea Therapeutics Corp. including key executives, insider trading, ownership, revenue and average growth rates. View detailed KTTA description & address. roberts eye colorWebWebull offers kinds of Pasithea Therapeutics Corp stock information, including NASDAQ:KTTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KTTA stock news, and many more online research tools to help you make informed decisions. You can practice and explore trading KTTA stock … roberts eyecare vestalWeb14 Jul 2024 · MIAMI BEACH, Fla., July 14, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel... roberts eyecare associatesWeb12 Oct 2024 · Pasithea acquired all of the issued and outstanding equity interests in AlloMek in exchange for a $1.05 million upfront cash payment and the issuance of 2,700,000 shares of restricted common stock ... roberts eyewearWeb06/30/2024. 0. -18,899. Sold Out. 1. Back to KTTA Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major ... roberts fabrication ncWeb16 Feb 2024 · Pasithea Therapeutics Corporation: NASDAQ:KTTA: NASDAQ: Common Stock Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 0.00: 0.0%: 0.3936: 0.3621: roberts fabrications